3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients

Albert J. S. Idema, Aswin L Hoffmann, Hieronymus D. Boogaarts, Esther G. C. Troost, Pieter Wesseling, Arend Heerschap, Winette T. A. van der Graaf, J. Andre Grotenhuis, Wim J. G. Oyen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1904-1910
JournalJournal of Nuclear Medicine
Volume53
Issue number12
DOIs
Publication statusPublished - Dec 2012

Keywords

  • PET/CT
  • F-18-fluorothymidine
  • FLT
  • high-grade glioma
  • overall survival

Cite this

Idema, A. J. S., Hoffmann, A. L., Boogaarts, H. D., Troost, E. G. C., Wesseling, P., Heerschap, A., van der Graaf, W. T. A., Grotenhuis, J. A., & Oyen, W. J. G. (2012). 3 '-Deoxy-3 '-F-18-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients. Journal of Nuclear Medicine, 53(12), 1904-1910. https://doi.org/10.2967/jnumed.112.105544